Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

March 01, 2016

Newsletter Sponsor

Live webinar: Using ultrasensitive immunoassays to search for mutant HTT protein in Huntington’s disease patient CSF

Reducing the amount of mutant HTT protein is a key therapeutic strategy for Huntington's disease. In this webinar, learn about a new sensitive and selective assay that measures polyglutamine-expanded HTT protein using the Singulex Single Molecule Counting technology, which displays increased sensitivity over other immunoassay-based methods.

	Industry News

Valeant Pharmaceuticals' CEO Returns Following Illness

AstraZeneca Enters Licensing Agreement with China Medical System Holdings for Hypertension Medicine

Senate Confirms New FDA Commissioner

inviCRO Acquires Molecular Neuroimaging (MNI) to Establish Full Spectrum Translational Imaging Capabilities

ImageIQ and T3 Labs Collaborate to Accelerate Biomedical Product Preclinical Testing

Pharm-Olam Named CRO for Global Phase II Lymphoma Study

	Featured Articles

Points to Consider in Filing Data for Shipment of Temperature Controlled Drug Substances/Products Points to Consider in Filing Data for Shipment of Temperature Controlled Drug Substances/Products Twenty years ago, the risk to drug substance/product quality due to temperature excursions during shipping was not generally appreciated. A series of studies led to several papers in USP PF which ... read more »

Will Biosimilars Make a Difference for the CMO/CDMO Market? Will Biosimilars Make a Difference for the CMO/CDMO Market? Given that over $60 billion of biopharmaceutical sales will lose patent protection by 2020, it is not surprising that most major biologics manufacturers have established biosimilar development ... read more »

	Featured Video

Interview with MPI Research at AAPS 2015
Interview with MPI Research at AAPS 2015
In this video, Mike Auerbach speaks with Lisa Yoder and Katie Jeschke from MPI Research about the CRO services MPI provides and how they are setting themselves apart in the industry. MPI Research ... read more »

Interview with INC Research at DIA 2015
Interview with INC Research at DIA 2015
In this video, Mike Auerbach of Pharmaceutical Outsourcing speaks with John Whitaker, Ph.D., VP of Clinical Innovation at INC Research. Learn about how INC Research is using disruptive innovation to ... read more »

	Featured Whitepaper

Proactive Pharmacovigilance Proactive Pharmacovigilance Pharmacovigilance is entering uncharted territory requiring industry, regulators, health care providers, and patients to address multiple unknowns. ... read more »

UNITHER Pharmaceuticals UNITHER Pharmaceuticals UNITHER Pharmaceuticals, with four manufacturing plants and one state-of-the-art R&D platform, is the world’s leading contract manufacturer of sterile... read more »

	Events


Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum		13th Annual Controlled Release

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA